Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin versus protease inhibitor switch for ritonavir-associated hypercholesterolaemia in adults with HIV
ACTRN12612000732886Phase 4Recruiting
- Sponsor
- St Vincent's Hospital Sydney
- Start
- Jul 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of rosuvastatin in hypercholesterolemia and human immunodeficiency virus infection (HIV) (2 arms), sponsored by St Vincent's Hospital Sydney. Primary endpoint: Change in fasting total cholesterol at Week 12. Started Jul 2012; status: recruiting.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemiahuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ACTRN12612000732886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000732886.